January 28, 2016, the FDA initiated a Class I recall of SPOTCHEM II Basic PANEL-1 Reagent Test Strips and SPOTCHEM II Glucose Reagent Test Strips. This Class I recall is the most serious type of recall as they involve situations in which there is a reasonable probability that use of the product will cause serious adverse health consequences or death. Click title to continue reading...
On January 27, 2016, the FDA identified the recall of Baxter IV solutions as a Class I recall, which is the most serious type of recall when there is a reasonable probability that use of the product will cause serious adverse health consequences or death. Click title to continue reading...
The CDC, on January 15, 2016, issued a travel alert (Level 2-Practice Enhanced Precautions) for people traveling to regions and certain countries where Zika virus transmission is ongoing: Brazil, Colombia, El Salvador, French Guiana, Guatemala, Haiti, Honduras, Martinique, Mexico, Panama, Paraguay, Suriname, Venezuela, and the Commonwealth of Puerto Rico. On January 22, 2016, the CDC added the following destinations to the Zika virus travel alerts: Barbados, Bolivia, Ecuador, Guadeloupe, Saint Martin, Guyana, Cape Verde, and Samoa. On January 26, 2016, the CDC added two more destinations to the Zika virus alerts, United States Virgin Islands and Dominican Republic. Click title to continue reading...